check_circleStudy Completed

Atrial Fibrillation

Treatment Pattern of NOACs (non-vitamin K oral anticoagulants) in Outpatient Users in Colombian Databases

Trial purpose

This population-based descriptive study will characterize first-time users of three NOACs (rivaroxaban, dabigatran and apixaban) in prevention of stroke in non-valvular atrial fibrillation (SPAF) patients and will assess the patterns of drug utilization in routine general practice in Colombia

Key Participants Requirements

Sex

All

Age

18 - N/A

Trial summary

Enrollment Goal
10528
Trial Dates
February 2018 - July 2018
Phase
Phase 4
Could I Receive a placebo
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many LocationsMany Locations, Colombia

Primary Outcome

  • Age
    date_rangeTime Frame:
    At Baseline
  • Sex
    date_rangeTime Frame:
    At Baseline
  • Co-morbidity
    date_rangeTime Frame:
    At Baseline
  • Healthcare utilization
    Primary Care Physicians visits, Outpatient visits and Hospital admissions
    date_rangeTime Frame:
    Up to 2 years
  • Proportion of Naive to non-naive patient
    date_rangeTime Frame:
    At Baseline
  • Dose at first prescription
    date_rangeTime Frame:
    Up to 6 years
  • Duration of treatment
    date_rangeTime Frame:
    Up to 6 years
  • Discontinuation
    date_rangeTime Frame:
    Up to 6 years
  • Switch to another study drug
    date_rangeTime Frame:
    Up to 6 years

Secondary Outcome

  • Time trends of usage of study medications
    date_rangeTime Frame:
    Up to 6 years

Trial design

Treatment Pattern of NOACs (non-vitamin K oral anticoagulants) in Outpatient Users in Colombian Databases – TREND Colombia
Trial Type
Observational
Intervention Type
Other
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information